US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

5.45

+0.30005.83%

Post-market: 5.450.00000.00%19:58 EDT

Volume:1.34M

Turnover:7.20M

Market Cap:753.40M

PE:-1.29

High:5.48

Open:5.25

Low:5.18

Close:5.15

Loading ...

Overview Company News Filings

Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com

Vir Biotechnology Up Over 65%, on Pace for Largest Percent Increase Since January 2021 -- Data Talk

Vir Biotech Shares Rise on Positive Data for Cancer Treatments

Vir Biotechnology Shares up 55.8% on Positive Data From Early-Stage Trials for Tumor Treatments

THOMSON REUTERS

BUZZ-Vir jumps on positive data from early-stage trials for tumor treatments

BRIEF-Vir Biotechnology Announces Encouraging Safety And Efficacy Data In Ongoing Dose Escalation Trials For Dual Masked T-Cell Engagers VIR-5818 In Solid Tumors And VIR-5500 In mCRPC

Vir Biotechnology presents safety, efficacy data in VIR-5818 and VIR-5500 trials

Vir Biotechnology Shares up 31.7% Premarket After Early-Stage Trial Data for Prostate Cancer Treatment

THOMSON REUTERS

Vir Biotechnology Inc - No Dose-Limiting Crs Observed for Vir-5818 or Vir-5500

THOMSON REUTERS

Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC

Vir Biotechnology price target lowered to $14 from $15 at BofA

BofA Securities Trims Price Target on Vir Biotechnology to $14 From $15, Maintains Neutral Rating

MT Newswires Live

US FDA revokes authorization for four COVID antibody drugs

US FDA revokes authorization for five COVID treatments

BRIEF-US FDA Revoked Emergency Use Authorization For Certain COVID Drugs As Of Dec 13

Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Vir Biotechnology's Tobevibart, Elebsiran Receive US, EU Designations for Hepatitis Delta Treatment

MT Newswires Live

Vir Biotechnology Receives FDA Breakthrough Therapy Designation and Ema Prime Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta

THOMSON REUTERS

Vir Biotechnology Inc - Phase 3 Eclipse Program to Begin in First Half of 2025

THOMSON REUTERS

Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VIR/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VIR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VIR\",,,,,undefined,":{"symbol":"VIR","market":"US","secType":"STK","nameCN":"Vir Biotechnology, Inc.","latestPrice":5.45,"timestamp":1749240000000,"preClose":5.15,"halted":0,"volume":1335113,"hourTrading":{"tag":"盘后","latestPrice":5.45,"preClose":5.45,"latestTime":"19:58 EDT","volume":19622,"amount":106922.83,"timestamp":1749254316336},"delay":0,"floatShares":93974139,"shares":138238003,"eps":-4.222767,"marketStatus":"Market Closed","change":0.3,"latestTime":"06-06 16:00:00 EDT","open":5.25,"high":5.48,"low":5.18,"amount":7198640.5110581005,"amplitude":0.058252,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.222767,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1570766400000,"exchange":"NASDAQ","adjPreClose":5.15,"postHourTrading":{"tag":"盘后","latestPrice":5.45,"preClose":5.45,"latestTime":"19:58 EDT","volume":19622,"amount":106922.83,"timestamp":1749254316336},"volumeRatio":0.888302163785972,"impliedVol":0.8835,"impliedVolPercentile":0.62},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VIR\",,,,,undefined,":{"symbol":"VIR","floatShares":93974139,"roa":"-23.52%","roe":"-44.59%","lyrEps":-3.830987,"volumeRatio":0.888302163785972,"shares":138238003,"dividePrice":0,"high":5.48,"amplitude":0.058252,"preClose":5.15,"low":5.18,"week52Low":4.32,"pbRate":"0.72","psRate":"36.12","week52High":14.45,"institutionHeld":0,"latestPrice":5.45,"eps":-4.222767,"divideRate":0,"volume":1335113,"delay":0,"ttmEps":-4.222767,"open":5.25,"prevYearClose":7.34,"prevWeekClose":4.94,"prevMonthClose":4.94,"prevQuarterClose":6.48,"fiveDayClose":4.94,"twentyDayClose":5.41,"sixtyDayClose":7.325},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VIR\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2502770446","title":"Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2502770446","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502770446?lang=en_us&edition=fundamental","pubTime":"2025-01-09 00:58","pubTimestamp":1736355480,"startTime":"0","endTime":"0","summary":"Shares of the battered biotech Vir Biotechnology were up more than 70% on Wednesday, as the company reported its first positive data since it executed a major pivot last summer.A hot stock during the pandemic era, when its shares climbed more than 500% between the start of 2020 to early 2021, Vir's gains have since evaporated.The new data comes six months after Vir announced a dramatic change in strategy. Once among the vanishingly few biotechs focused exclusively on infectious disease, Vir has pivoted to cancer, among the most crowded areas for biotech drug development.Wednesday brought the first major update from the company since the August pivot, and the news was good.Vir said that two early-stage drugs, VIR-5818 and VIR-5500, showed \"compelling early clinical response signals\" in an early trial in patients with various solid tumor cancers.Both drugs are based on a technology that Vir has licensed from Sanofi called PRO-XTEN, which helps guide and disguise a type of immunotherapy c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","GSK","BK4139","BK4202","BK4568","LU1829250122.USD","ALNY","BK4535","BK4532","BK4548","GSK.UK","VIR","BK4588","PFE","BK4585","JANX","FORD"],"gpt_icon":1},{"id":"2501771451","title":"Vir Biotechnology Up Over 65%, on Pace for Largest Percent Increase Since January 2021 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2501771451","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501771451?lang=en_us&edition=fundamental","pubTime":"2025-01-08 23:49","pubTimestamp":1736351340,"startTime":"0","endTime":"0","summary":"Vir Biotechnology, Inc.  is currently at $13.04, up $5.15 or 65.27%. --On pace for largest percent increase since Jan. 26, 2021, when it rose 74.32%. --Down 84.3% from its all-time closing high of $83.07 on Jan. 27, 2021. --Up 26.48% from 52 weeks ago , when it closed at $10.31. --Traded as high as $13.67; highest intraday level since Aug. 10, 2023, when it hit $13.85. --Up 73.26% at today's intraday high; largest intraday percent increase since Jan. 27, 2021, when it rose as much as 82.23%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4568","BK4535","VIR"],"gpt_icon":0},{"id":"2501776447","title":"Vir Biotech Shares Rise on Positive Data for Cancer Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2501776447","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501776447?lang=en_us&edition=fundamental","pubTime":"2025-01-08 23:14","pubTimestamp":1736349240,"startTime":"0","endTime":"0","summary":"Vir Biotechnology shares were up 67% to $13.15 after the company reported encouraging initial Phase 1 data for its dual-masked T-cell engagers, VIR-5818 and VIR-5500.The clinical-stage biopharmaceutical company said VIR-5818 targets HER2-expressing solid tumors, showing tumor shrinkage in 50% of heavily pretreated participants, with no significant adverse events.VIR-5818 is being tested alone and with pembrolizumab across various cancers, including breast and colorectal cancer.The San Francisco company said VIR-5500, for metastatic castration-resistant prostate cancer, has shown PSA reductions in all participants.Both drugs exhibit favorable safety profiles with no dose-limiting cytokine release syndrome or toxicities, suggesting effective tumor-specific activation due to the PRO-XTEN masking technology. Both studies continue dose escalation, with no maximum tolerated dose yet determined, and are exploring less frequent dosing due to prolonged drug half-life.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4535","VIR","BK4568"],"gpt_icon":0},{"id":"2501787507","title":"Vir Biotechnology Shares up 55.8% on Positive Data From Early-Stage Trials for Tumor Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2501787507","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501787507?lang=en_us&edition=fundamental","pubTime":"2025-01-08 22:32","pubTimestamp":1736346768,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nFWN3O40J4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VIR","BK4568","BK4535","BK4139","BK4585"],"gpt_icon":0},{"id":"2501249627","title":"BUZZ-Vir jumps on positive data from early-stage trials for tumor treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2501249627","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501249627?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:17","pubTimestamp":1736342237,"startTime":"0","endTime":"0","summary":"BUZZ-Vir jumps on positive data from early-stage trials for tumor treatments** Drug developer Vir Biotechnology's VIR.O shares rise 33.2% to $10.50 premarket** Co says its drugs VIR-5818 and VIR-5500 showed compelling response in patients with various solid tumors during early-stage trials** Says VIR-5818 showed tumor shrinkage in 50% of patients with various HER2 positive cancers ** HER2 is a protein that stimulates quick growth of cancer cells** VIR says all 12 patients who took VIR-5500 showed a decline in prostate-specific antigen levels, which indicate the presence of prostate cancer** Up to last close, stock down 25.6% in the last 12 months  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nL4N3O40UE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIR","BK4568","BK4139","BK4585","BK4535"],"gpt_icon":0},{"id":"2501218047","title":"BRIEF-Vir Biotechnology Announces Encouraging Safety And Efficacy Data In Ongoing Dose Escalation Trials For Dual Masked T-Cell Engagers VIR-5818 In Solid Tumors And VIR-5500 In mCRPC","url":"https://stock-news.laohu8.com/highlight/detail?id=2501218047","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501218047?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:57","pubTimestamp":1736341024,"startTime":"0","endTime":"0","summary":"Jan 8  - Vir Biotechnology Inc   :   * VIR BIOTECHNOLOGY ANNOUNCES ENCOURAGING SAFETY AND EFFICACY DATA IN ONGOING DOSE ESCALATION TRIALS FOR DUAL MASKED T-CELL ENGAGERS VIR-5818 IN SOLID TUMORS AND VIR-5500 IN MCRPC   * VIR BIOTECHNOLOGY INC - VIR-5818 SHOWS 50% TUMOR SHRINKAGE IN HER2 CANCERS AT ≥400 ΜG/KG   * VIR BIOTECHNOLOGY INC - NO DOSE-LIMITING CRS OBSERVED FOR VIR-5818 OR VIR-5500   * VIR BIOTECHNOLOGY INC: PROMISING SAFETY PROFILE WITH MTD NOT YET REACHED FOR VIR-5818 OR VIR-5500Source text:   Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BRIEF-Vir Biotechnology Announces Encouraging Safety And Efficacy Data In Ongoing Dose Escalation Trials For Dual Masked T-Cell Engagers VIR-5818 In Solid Tumors And VIR-5500 In mCRPC","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4568","BK4535","VIR"],"gpt_icon":0},{"id":"2501721315","title":"Vir Biotechnology presents safety, efficacy data in VIR-5818 and VIR-5500 trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2501721315","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501721315?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:56","pubTimestamp":1736340994,"startTime":"0","endTime":"0","summary":"Vir Biotechnology (VIR) is presenting initial Phase 1 data from two of its dual-masked T-cell engagers: VIR-5818, targeting a variety of HER2-expre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vir-biotechnology-presents-safety-efficacy-data-in-vir-5818-and-vir-5500-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vir-biotechnology-presents-safety-efficacy-data-in-vir-5818-and-vir-5500-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4535","BK4139","BK4585","VIR"],"gpt_icon":0},{"id":"2501270729","title":"Vir Biotechnology Shares up 31.7% Premarket After Early-Stage Trial Data for Prostate Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2501270729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501270729?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:52","pubTimestamp":1736340767,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nFWN3O40AA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4535","BK4139","VIR","BK4568"],"gpt_icon":0},{"id":"2501291567","title":"Vir Biotechnology Inc - No Dose-Limiting Crs Observed for Vir-5818 or Vir-5500","url":"https://stock-news.laohu8.com/highlight/detail?id=2501291567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501291567?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:45","pubTimestamp":1736340300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA14MXVR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VIR","BK4568","BK4535","BK4585","BK4139"],"gpt_icon":0},{"id":"2501729224","title":"Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC","url":"https://stock-news.laohu8.com/highlight/detail?id=2501729224","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501729224?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:45","pubTimestamp":1736340300,"startTime":"0","endTime":"0","summary":"– Compelling early clinical response signals for VIR-5818 and VIR-5500 in heavily pretreated patients with various solid tumors. ○ VIR-5818: In patients receiving doses ≥400 g/kg, tumor shrinkage observed in 50%  of participants with various HER2-expressing cancers; confirmed partial responses in 33% (2/6) of participants with HER2-positive CRC. ○ VIR-5500: PSA declines in 100%  and PSA50 response confirmed in 58%  of mCRPC patients with first step dose ≥120 g/kg. – Promising safety profile with MTD not yet reached for VIR-5818 or VIR-5500 and no dose-limiting cytokine release syndrome  observed; no CRS greater than grade 2 reported. Despite availability of HER2-targeting therapies, there remains a significant unmet need for treatments with novel mechanisms of action to improve tolerability and extend survival. Currently, no HER2-directed immunotherapies are approved for solid tumors. The preliminary safety and efficacy data of VIR-5818 support the tumor-specific activation of PRO-XTEN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vir-biotechnology-announces-encouraging-safety-124500366.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B66KJ199.SGD","BK4217","BK4139","BK4548","BK4588","LU1093756325.SGD","LU0347712357.USD","BK4213","LU1093756168.USD","IE0031619046.USD","LU0456854461.SGD","BK4585","BK4533","BK4121","LU2413666699.HKD","MTD","BK4084","CRS","IE00B7SZL793.SGD","CRC","LU1721428933.USD","BK4568","PSA","BK4567","LU0266512127.USD","VIR","IE00B19Z4B17.USD","LU2413666426.HKD","BK4006","BK4535","LU2065731478.USD"],"gpt_icon":0},{"id":"2501672920","title":"Vir Biotechnology price target lowered to $14 from $15 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2501672920","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501672920?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:25","pubTimestamp":1736339155,"startTime":"0","endTime":"0","summary":"BofA lowered the firm’s price target on Vir Biotechnology  to $14 from $15 and keeps a Neutral rating on the shares. While political and rate uncertainty continues to be an overhang, the firm views the health of the Biopharma sector as “markedly improved from 2022 lows.” For stocks in its coverage, the firm continues to like late-stage clinical or early launch stories, although it sees Phase 1 clinical programs with derisking data and near-term catalysts as “increasingly areas of investor focus,” the analyst tells investors in a sector outlook note.Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. FDA revokes EUAs for some antibody treatments for COVID-19. Biotech Alert: Searches spiking for these stocks today. Closing Bell Movers: RH soars 20% on earnings, guidance raise. Vir receives FDA, EMA designations for tobevibart and elebsiran. Vir has positive r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/vir-biotechnology-price-target-lowered-122555769.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vir-biotechnology-price-target-lowered-122555769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VIR"],"gpt_icon":0},{"id":"2501781486","title":"BofA Securities Trims Price Target on Vir Biotechnology to $14 From $15, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2501781486","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501781486?lang=en_us&edition=fundamental","pubTime":"2025-01-08 00:17","pubTimestamp":1736266643,"startTime":"0","endTime":"0","summary":"Vir Biotechnology (VIR) has an average rating of overweight and mean price target of $29.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from m","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VIR"],"gpt_icon":0},{"id":"2493240796","title":"US FDA revokes authorization for four COVID antibody drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2493240796","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493240796?lang=en_us&edition=fundamental","pubTime":"2024-12-24 02:13","pubTimestamp":1734977591,"startTime":"0","endTime":"0","summary":"UPDATE 1-US FDA revokes authorization for four COVID antibody drugsAdds background throughoutDec 23  - The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from Eli Lilly LLY.N and Regeneron REGN.O. The shelf life of the drugs had expired and they had not been authorized for administration to patients for more than a year due to the circulation of non-susceptible variants, the FDA said in letters dated earlier this month and posted on its website on Monday.The FDA revoked the authorization for Lilly's bebtelovimab, AstraZeneca's AZN.L Evusheld, GSK's GSK.L sotrovimab and Regeneron's REGEN-COV.The companies also do not intend to offer the products in the U.S. anymore, according to the FDA.The FDA said the companies would notify customers and providers about the revocation with instructions for product destruction or return.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nL4N3NO0Z0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2279689827.SGD","LU2361045086.USD","LU0882574055.USD","LU0949170772.SGD","LU1983299246.USD","BK4139","LU1003076772.USD","LU1623119135.USD","LU0211327993.USD","LU2237443382.USD","LU0889566641.SGD","LU2237443465.HKD","LU0820561818.USD","SGXZ57979304.SGD","SGXZ99366536.SGD","IE00BWDBJ516.SGD","LU0320765059.SGD","IE00BJLML261.HKD","SG9999015978.USD","LU0321505439.SGD","LU2112291526.USD","LLY","LU0256863811.USD","LU1119994496.HKD","LU0094547139.USD","LU0672654240.SGD","LU2023251221.USD","LU2237438978.USD","SGXZ31699556.SGD","LU2602419157.SGD","LU0354030511.USD","IE00BK4W5L77.USD","LU0466842654.USD","LU0708995401.HKD","LU0689472784.USD","LU0047473722.EUR","AZN.UK","SG9999015952.SGD","LU0122379950.USD","LU2264538146.SGD","VIR","LU2361044949.HKD","LU2023250504.SGD","LU0225284248.USD","LU0203347892.USD","LU0963555726.SGD","03165","LU0061475181.USD","GSK.UK","REGN"],"gpt_icon":1},{"id":"2493931417","title":"US FDA revokes authorization for five COVID treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2493931417","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493931417?lang=en_us&edition=fundamental","pubTime":"2024-12-24 01:23","pubTimestamp":1734974621,"startTime":"0","endTime":"0","summary":"US FDA revokes authorization for five COVID treatments Dec 23  - The U.S. Food and Drug Administration said on Monday it had revoked the emergency use authorization for five COVID-19 treatments, including those from Eli Lilly LLY.N and Regeneron REGN.O.   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nL4N3NO0YX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","IE00BQJZX424.USD","LU1267930227.SGD","LU0109394709.USD","REGN","SGXZ99366536.SGD","GSK.UK","LU2491050071.SGD","BK4535","LU0943347566.SGD","LU0211328371.USD","LLY","LU0053666078.USD","SG9999014880.SGD","LU2023250504.SGD","LU0006306889.USD","LU1093756325.SGD","LU0889566641.SGD","LU0321505868.SGD","LU0971552830.HKD","AZN.UK","LU0964806797.USD","IE00BK4W5M84.HKD","LU0320765992.SGD","LU1098665638.USD","LU1323610961.USD","LU2237443465.HKD","LU2324357040.USD","LU1291159041.SGD","LU0171293334.USD","LU0385154629.USD","LU1551013425.SGD","LU1228905540.USD","LU0738911758.USD","LU2279689827.SGD","SG9999018857.SGD","LU0456855351.SGD","LU0094547139.USD","03165","LU1261432733.SGD","LU1119994496.HKD","LU2237443978.SGD","LU2362540622.SGD","LU0784385840.USD","LU1019632923.USD","IE0034235188.USD","VIR","LU0211327993.USD","LU1228905037.USD","LU1267930730.SGD"],"gpt_icon":1},{"id":"2493793667","title":"BRIEF-US FDA Revoked Emergency Use Authorization For Certain COVID Drugs As Of Dec 13","url":"https://stock-news.laohu8.com/highlight/detail?id=2493793667","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493793667?lang=en_us&edition=fundamental","pubTime":"2024-12-24 01:16","pubTimestamp":1734974168,"startTime":"0","endTime":"0","summary":"Dec 23  - US FDA:   * US FDA: REVOKED EMERGENCY USE AUTHORIZATION FOR LILLY'S BEBTELOVIMAB AS OF DEC 13 - WEBSITE   * US FDA: REVOKED EMERGENCY USE AUTHORIZATION FOR ASTRAZENECA'S EVUSHELD AS OF DEC 13 - WEBSITE   * US FDA: REVOKED EMERGENCY USE AUTHORIZATION FOR REGENERON'S REGEN-COV AS OF DEC 13 - WEBSITE   * US FDA: REVOKED EMERGENCY USE AUTHORIZATION FOR GSK AND VIR BIOTECHNOLOGY'S SOTROVIMAB AS OF DEC 13 - WEBSITEFurther company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930730.SGD","BK4139","LU2361045086.USD","LU0256863902.USD","SGXZ51526630.SGD","LU0640476718.USD","LU2265009873.SGD","LU0889565916.HKD","LU0417517546.SGD","REGN","LU1983299246.USD","LU2237443465.HKD","LU0006306889.USD","BK4007","BK4535","IE0004445239.USD","LU2237443622.USD","LU2361044949.HKD","LU1814569148.SGD","LU1868836757.USD","LU1988902786.USD","LU2362541513.USD","LU2112291526.USD","LU2468319806.SGD","LU1974910355.USD","LU1623119135.USD","LU1868836914.USD","SG9999015978.USD","LLY","LU2063271972.USD","LU1291159041.SGD","IE0002141913.USD","VIR","LU0238689110.USD","BK4568","LU0820561818.USD","LU1023059063.AUD","LU2491050154.USD","LU0320765992.SGD","SG9999014880.SGD","SG9999014906.USD","SG9999015986.USD","SG9999018865.SGD","LU2023250504.SGD","LU1551013342.USD","LU0079474960.USD","LU0114720955.EUR","LU0689472784.USD","LU0061475181.USD","LU0354030511.USD"],"gpt_icon":1},{"id":"2492499184","title":"Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2492499184","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492499184?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:30","pubTimestamp":1734532200,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, December 18, 2024----Vir Biotechnology Inc.  today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, at 4:30 p.m. PT in San Francisco, California.A live webcast of the presentation will be made available under Events & Presentations in the Investors section of the Vir Biotechnology website at www.vir.bio and will be archived there for 30 days.Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple double-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infe","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fm6dN3HvbX1jJtOZZviRfA--~B/aD0yMzM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2f849826296cb2b118e4a4c58fa0947d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fm6dN3HvbX1jJtOZZviRfA--~B/aD0yMzM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2f849826296cb2b118e4a4c58fa0947d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vir-biotechnology-present-43rd-annual-143000828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4535","LU1548497426.USD","LU2089283258.USD","BK4581","LU1720051108.HKD","LU1732800096.USD","BK4534","BK4588","VIR","LU0320765646.SGD","LU0158827948.USD","LU0971096721.USD","IE00BZ1G4Q59.USD","LU0106261372.USD","LU1989772840.SGD","LU2347655156.SGD","LU2357305700.SGD","LU2271345857.HKD","BK4127","LU2111349929.HKD","LU0225283273.USD","LU1162221912.USD","BK4137","LU2023251221.USD","LU1732799900.SGD","LU1074936037.SGD","BK4504","BK4568","HCSG","LU2089284900.SGD","LU0098860793.USD","IE00BKVL7J92.USD","LU0006306889.USD","LU1668664300.SGD","LU2028103732.USD","LU0912757837.SGD","LU0795875086.SGD","LU0106831901.USD","LU0795875169.SGD","LU0314104364.USD","BK4585","LU0158827781.USD","LU1363072403.SGD","BK4139","LU1720051017.SGD","BK4516","LU1989772923.USD","LU0267386448.USD"],"gpt_icon":0},{"id":"2491357838","title":"Vir Biotechnology's Tobevibart, Elebsiran Receive US, EU Designations for Hepatitis Delta Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2491357838","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491357838?lang=en_us&edition=fundamental","pubTime":"2024-12-13 05:36","pubTimestamp":1734039387,"startTime":"0","endTime":"0","summary":"Vir Biotechnology  said Thursday that the US Food and Drug Administration granted breakthrough therapy designation to tobevibart and elebsiran for the treatment of chronic hepatitis delta.The European Medicines Agency also gave priority medicine designation to tobevibart and elebsiran, according to the company.These designations are backed by safety and efficacy data from the phase 2 Solstice study, Vir added.Shares of Vir Biotechnology were up nearly 4% in after-hours activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","BK4139","VIR","BK4585","BK4535","BK4156"],"gpt_icon":0},{"id":"2491561354","title":"Vir Biotechnology Receives FDA Breakthrough Therapy Designation and Ema Prime Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta","url":"https://stock-news.laohu8.com/highlight/detail?id=2491561354","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491561354?lang=en_us&edition=fundamental","pubTime":"2024-12-13 05:05","pubTimestamp":1734037501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA3SRRGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","VIR","BK4139","BK4568","BK4585"],"gpt_icon":0},{"id":"2491354612","title":"Vir Biotechnology Inc - Phase 3 Eclipse Program to Begin in First Half of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2491354612","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491354612?lang=en_us&edition=fundamental","pubTime":"2024-12-13 05:05","pubTimestamp":1734037501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA3SRRGT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4535","BK4139","BK4585","VIR"],"gpt_icon":0},{"id":"2491354421","title":"Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta","url":"https://stock-news.laohu8.com/highlight/detail?id=2491354421","media":"Business Wire","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491354421?lang=en_us&edition=fundamental","pubTime":"2024-12-13 05:05","pubTimestamp":1734037500,"startTime":"0","endTime":"0","summary":"– Designations aim to expedite the development and review of promising therapies for serious conditions with unmet medical needs –。SAN FRANCISCO, December 12, 2024----Vir Biotechnology, Inc.  today announced that tobevibart and elebsiran have received U.S. Food and Drug Administration  Breakthrough Therapy designation and European Medicines Agency  Priority Medicines  designation for the treatment of chronic hepatitis delta . The designations are supported by compelling positive safety and efficacy data from the Phase 2 SOLSTICE trial, from which the Company recently presented new data at AASLD The Liver Meeting in San Diego, U.S. Vir Biotechnology’s Phase 3 ECLIPSE registrational program evaluating tobevibart and elebsiran in CHD will commence in the first half of 2025.SOLSTICE is a Phase 2 study to evaluate the safety, tolerability, and efficacy of tobevibart,","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wXNPCu3vSLcC52uz19vPqw--~B/aD0yMzM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bb9e8dae459d7a75ec75adc12df64de0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wXNPCu3vSLcC52uz19vPqw--~B/aD0yMzM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bb9e8dae459d7a75ec75adc12df64de0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vir-biotechnology-receives-fda-breakthrough-210500608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4535","BK4079","CHD","LU1878469433.USD","BK4504","BK4568","BK4588","BK4599","BK4018","COMP","VIR","BK4139","HDV","ALT","BK4585","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":100,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VIR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"VIR","fiscalQuarterEnding":"2025/03","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2025-02-26","symbol":"VIR","fiscalQuarterEnding":"2024/12","expectedEps":-0.85,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":-0.76},{"market":"US","date":"2024-10-31","symbol":"VIR","fiscalQuarterEnding":"2024/09","expectedEps":-0.96,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"post","actualEps":-1.56},{"market":"US","date":"2024-08-01","symbol":"VIR","fiscalQuarterEnding":"2024/06","expectedEps":-0.93,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-1.02},{"market":"US","date":"2024-05-02","symbol":"VIR","fiscalQuarterEnding":"2024/03","expectedEps":-0.99,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714622400000,"reportTimeType":"post","actualEps":-0.48}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VIR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VIR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.6667,"hold":0.2222,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1736395200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VIR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VIR","date":"2025-06-06","current":-1.232454,"percent":0.744508,"low":-69.111846,"twenty":-21.294051,"median":-2.47986,"eighty":2.689421,"high":7.002434,"avg":-9.739465,"sd":14.257399,"marketCap":711925715},"quantilePoints":[{"date":"2020-06-12","current":-18.071876,"twenty":-20.171365,"median":-16.218215,"eighty":-10.560096,"marketCap":4034600519},{"date":"2020-06-19","current":-21.895382,"twenty":-20.171365,"median":-16.558845,"eighty":-10.863639,"marketCap":4888209747},{"date":"2020-06-26","current":-20.506457,"twenty":-20.522119,"median":-16.966448,"eighty":-10.911567,"marketCap":4578127942},{"date":"2020-07-02","current":-21.293338,"twenty":-20.608862,"median":-17.022364,"eighty":-11.366721,"marketCap":4753801664},{"date":"2020-07-10","current":-27.516386,"twenty":-21.096882,"median":-17.593937,"eighty":-11.594099,"marketCap":6143115815},{"date":"2020-07-17","current":-29.024675,"twenty":-21.342854,"median":-17.781416,"eighty":-11.630413,"marketCap":6479845834},{"date":"2020-07-24","current":-27.1492,"twenty":-21.709488,"median":-17.947049,"eighty":-11.660982,"marketCap":6061140342},{"date":"2020-07-31","current":-26.866108,"twenty":-23.499776,"median":-18.050752,"eighty":-11.696719,"marketCap":5997939265},{"date":"2020-08-07","current":-29.268082,"twenty":-25.381011,"median":-18.222473,"eighty":-11.739603,"marketCap":6534187185},{"date":"2020-08-14","current":-30.390456,"twenty":-26.518469,"median":-18.341211,"eighty":-11.834306,"marketCap":6700852378},{"date":"2020-08-21","current":-30.459604,"twenty":-27.00788,"median":-18.395278,"eighty":-12.122863,"marketCap":6716098914},{"date":"2020-08-28","current":-23.994285,"twenty":-26.96982,"median":-18.449036,"eighty":-12.201276,"marketCap":5290547839},{"date":"2020-09-04","current":-16.462937,"twenty":-26.886573,"median":-18.49618,"eighty":-12.2971,"marketCap":3629946007},{"date":"2020-09-11","current":-16.353453,"twenty":-26.768229,"median":-18.417606,"eighty":-12.341771,"marketCap":3605805659},{"date":"2020-09-18","current":-18.854299,"twenty":-26.564596,"median":-18.436464,"eighty":-12.457917,"marketCap":4157222029},{"date":"2020-09-25","current":-20.692478,"twenty":-26.451055,"median":-18.447105,"eighty":-12.568701,"marketCap":4562525766},{"date":"2020-10-02","current":-19.2058,"twenty":-26.271106,"median":-18.543324,"eighty":-12.661618,"marketCap":4234725251},{"date":"2020-10-09","current":-23.562111,"twenty":-25.946609,"median":-18.634698,"eighty":-12.725944,"marketCap":5195256992},{"date":"2020-10-16","current":-22.726575,"twenty":-25.486745,"median":-18.761922,"eighty":-12.761681,"marketCap":5011028020},{"date":"2020-10-23","current":-20.001,"twenty":-25.205075,"median":-18.795226,"eighty":-12.813499,"marketCap":4410060410},{"date":"2020-10-30","current":-18.116722,"twenty":-25.061466,"median":-18.816509,"eighty":-12.859957,"marketCap":3994592316},{"date":"2020-11-06","current":-18.692954,"twenty":-24.84826,"median":-18.77834,"eighty":-12.884973,"marketCap":4121646779},{"date":"2020-11-13","current":-13.38442,"twenty":-24.718031,"median":-18.712375,"eighty":-12.884973,"marketCap":3436944967},{"date":"2020-11-20","current":-14.396437,"twenty":-24.61672,"median":-18.634698,"eighty":-12.929645,"marketCap":3696817752},{"date":"2020-11-27","current":-14.70401,"twenty":-24.45307,"median":-18.566269,"eighty":-12.965382,"marketCap":3775798696},{"date":"2020-12-04","current":-15.582084,"twenty":-24.242065,"median":-18.449036,"eighty":-12.984253,"marketCap":4001276554},{"date":"2020-12-11","current":-15.939266,"twenty":-24.115294,"median":-18.437938,"eighty":-13.021386,"marketCap":4092996360},{"date":"2020-12-18","current":-15.234823,"twenty":-24.015029,"median":-18.391807,"eighty":-13.07438,"marketCap":3912104520},{"date":"2020-12-24","current":-14.654402,"twenty":-23.98737,"median":-18.362336,"eighty":-13.080651,"marketCap":3763059834},{"date":"2020-12-31","current":-13.285202,"twenty":-23.959711,"median":-18.341211,"eighty":-13.084295,"marketCap":3411467243},{"date":"2021-01-08","current":-13.801132,"twenty":-23.913612,"median":-18.222473,"eighty":-13.084295,"marketCap":3543951408},{"date":"2021-01-15","current":-19.501169,"twenty":-23.892018,"median":-18.180108,"eighty":-13.156187,"marketCap":5007646652},{"date":"2021-01-22","current":-20.106395,"twenty":-23.828336,"median":-18.22838,"eighty":-13.156213,"marketCap":5163060768},{"date":"2021-01-29","current":-32.017437,"twenty":-23.966626,"median":-18.344213,"eighty":-13.200926,"marketCap":8221661534},{"date":"2021-02-05","current":-33.098906,"twenty":-24.343132,"median":-18.364502,"eighty":-13.220571,"marketCap":8499368726},{"date":"2021-02-12","current":-34.582205,"twenty":-25.029197,"median":-18.417606,"eighty":-13.229835,"marketCap":8880260700},{"date":"2021-02-19","current":-37.990321,"twenty":-25.946609,"median":-18.442293,"eighty":-13.251864,"marketCap":9755420519},{"date":"2021-02-26","current":-26.807359,"twenty":-26.74473,"median":-18.543324,"eighty":-13.268336,"marketCap":8006419786},{"date":"2021-03-05","current":-19.33828,"twenty":-26.74473,"median":-18.543324,"eighty":-13.279249,"marketCap":5775667346},{"date":"2021-03-12","current":-22.608409,"twenty":-26.564596,"median":-18.589214,"eighty":-13.344733,"marketCap":6752340621},{"date":"2021-03-19","current":-22.972233,"twenty":-26.467899,"median":-18.680796,"eighty":-13.394592,"marketCap":6861001914},{"date":"2021-03-26","current":-22.056254,"twenty":-26.448093,"median":-18.761922,"eighty":-13.447755,"marketCap":6587431128},{"date":"2021-04-01","current":-21.536804,"twenty":-26.326359,"median":-18.794758,"eighty":-13.484629,"marketCap":6432289600},{"date":"2021-04-09","current":-18.760184,"twenty":-26.01794,"median":-18.806101,"eighty":-13.499198,"marketCap":5603010277},{"date":"2021-04-16","current":-20.173831,"twenty":-25.592479,"median":-18.854299,"eighty":-13.518749,"marketCap":6025217173},{"date":"2021-04-23","current":-21.274301,"twenty":-25.228475,"median":-18.936367,"eighty":-13.546661,"marketCap":6353889002},{"date":"2021-04-30","current":-20.765388,"twenty":-25.093735,"median":-18.992594,"eighty":-13.567317,"marketCap":6201894520},{"date":"2021-05-07","current":-14.315389,"twenty":-24.897816,"median":-18.986408,"eighty":-13.594751,"marketCap":5587811838},{"date":"2021-05-14","current":-14.062197,"twenty":-24.735211,"median":-18.920476,"eighty":-13.518749,"marketCap":5488981561},{"date":"2021-05-21","current":-15.084962,"twenty":-24.707498,"median":-18.870312,"eighty":-13.546661,"marketCap":5888203864},{"date":"2021-05-28","current":-13.962252,"twenty":-24.643575,"median":-18.795693,"eighty":-13.567317,"marketCap":5449969610},{"date":"2021-06-04","current":-14.971692,"twenty":-24.558169,"median":-18.761922,"eighty":-13.583842,"marketCap":5843990319},{"date":"2021-06-11","current":-15.168249,"twenty":-24.488683,"median":-18.758009,"eighty":-13.629466,"marketCap":5920713824},{"date":"2021-06-18","current":-15.374802,"twenty":-24.265114,"median":-18.692954,"eighty":-13.641825,"marketCap":6001338523},{"date":"2021-06-25","current":-15.161586,"twenty":-24.144105,"median":-18.594985,"eighty":-13.666934,"marketCap":5918113027},{"date":"2021-07-02","current":-13.86897,"twenty":-24.021944,"median":-18.543324,"eighty":-13.700632,"marketCap":5413558455},{"date":"2021-07-09","current":-12.996121,"twenty":-23.994285,"median":-18.445174,"eighty":-13.637424,"marketCap":5072854080},{"date":"2021-07-16","current":-12.266526,"twenty":-23.959711,"median":-18.417606,"eighty":-13.535387,"marketCap":4788066835},{"date":"2021-07-23","current":-12.289847,"twenty":-23.913612,"median":-18.364502,"eighty":-13.401373,"marketCap":4797169623},{"date":"2021-07-30","current":-11.876743,"twenty":-23.892018,"median":-18.344213,"eighty":-13.265359,"marketCap":4635920224},{"date":"2021-08-06","current":-16.831824,"twenty":-23.812416,"median":-18.22838,"eighty":-13.231622,"marketCap":5005043984},{"date":"2021-08-13","current":-18.619547,"twenty":-23.68312,"median":-18.222473,"eighty":-13.23932,"marketCap":5536633990},{"date":"2021-08-20","current":-20.411662,"twenty":-23.677357,"median":-18.341211,"eighty":-13.265359,"marketCap":6069530113},{"date":"2021-08-27","current":-21.94023,"twenty":-23.562111,"median":-18.363419,"eighty":-13.27032,"marketCap":6524059160},{"date":"2021-09-03","current":-21.505379,"twenty":-23.481585,"median":-18.391807,"eighty":-13.285202,"marketCap":6394753483},{"date":"2021-09-10","current":-22.708907,"twenty":-23.43361,"median":-18.398749,"eighty":-13.364576,"marketCap":6752629801},{"date":"2021-09-17","current":-23.95636,"twenty":-23.43361,"median":-18.442293,"eighty":-13.397982,"marketCap":7123567299},{"date":"2021-09-24","current":-19.247666,"twenty":-23.345008,"median":-18.543324,"eighty":-13.463215,"marketCap":5723408856},{"date":"2021-10-01","current":-15.088026,"twenty":-23.152066,"median":-18.566269,"eighty":-13.490582,"marketCap":4486515158},{"date":"2021-10-08","current":-16.2652,"twenty":-23.077045,"median":-18.449036,"eighty":-13.504837,"marketCap":4836554768},{"date":"2021-10-15","current":-17.170042,"twenty":-22.995307,"median":-18.437938,"eighty":-13.529841,"marketCap":5105615066},{"date":"2021-10-22","current":-17.661995,"twenty":-22.973156,"median":-18.395533,"eighty":-13.557936,"marketCap":5251900276},{"date":"2021-10-29","current":-16.572671,"twenty":-22.775707,"median":-18.371233,"eighty":-13.571061,"marketCap":4927983025},{"date":"2021-11-05","current":-39.985865,"twenty":-22.973156,"median":-18.364502,"eighty":-13.616568,"marketCap":4091313770},{"date":"2021-11-12","current":-42.352271,"twenty":-23.345008,"median":-18.39367,"eighty":-13.635435,"marketCap":4333442064},{"date":"2021-11-19","current":-41.891782,"twenty":-23.67851,"median":-18.436464,"eighty":-13.655028,"marketCap":4286325207},{"date":"2021-11-26","current":-46.048981,"twenty":-23.900656,"median":-18.445174,"eighty":-13.681944,"marketCap":4711685724},{"date":"2021-12-03","current":-56.678621,"twenty":-24.008115,"median":-18.543324,"eighty":-13.707988,"marketCap":5799299845},{"date":"2021-12-10","current":-55.770433,"twenty":-24.548491,"median":-18.600757,"eighty":-13.743555,"marketCap":5706374932},{"date":"2021-12-17","current":-68.971141,"twenty":-24.84826,"median":-18.680796,"eighty":-13.785624,"marketCap":7057058173},{"date":"2021-12-23","current":-53.404027,"twenty":-25.592479,"median":-18.734105,"eighty":-13.818991,"marketCap":5464246638},{"date":"2021-12-31","current":-53.557524,"twenty":-26.46938,"median":-18.761922,"eighty":-13.852391,"marketCap":5479952257},{"date":"2022-01-07","current":-43.017423,"twenty":-26.927502,"median":-18.795226,"eighty":-13.862307,"marketCap":4401499747},{"date":"2022-01-14","current":-49.502655,"twenty":-27.324183,"median":-18.816509,"eighty":-13.864972,"marketCap":5065062153},{"date":"2022-01-21","current":-42.79997,"twenty":-27.794319,"median":-18.854299,"eighty":-13.871794,"marketCap":4379250120},{"date":"2022-01-28","current":-43.45233,"twenty":-28.034966,"median":-18.91419,"eighty":-13.895473,"marketCap":4445999001},{"date":"2022-02-04","current":-42.748804,"twenty":-28.486175,"median":-18.957765,"eighty":-13.948449,"marketCap":4374014913},{"date":"2022-02-11","current":-41.009176,"twenty":-29.052424,"median":-19.030049,"eighty":-13.964754,"marketCap":4196017897},{"date":"2022-02-18","current":-38.540439,"twenty":-29.263257,"median":-19.180904,"eighty":-13.980393,"marketCap":3943419190},{"date":"2022-02-25","current":6.905661,"twenty":-29.454001,"median":-19.180904,"eighty":-13.962252,"marketCap":3650221873},{"date":"2022-03-04","current":5.806915,"twenty":-29.268082,"median":-19.030049,"eighty":-13.862307,"marketCap":3069442615},{"date":"2022-03-11","current":5.46651,"twenty":-29.243958,"median":-18.957765,"eighty":-13.762363,"marketCap":2889509772},{"date":"2022-03-18","current":6.537786,"twenty":-29.205444,"median":-18.91419,"eighty":-13.637424,"marketCap":3455769013},{"date":"2022-03-25","current":5.459001,"twenty":-29.135173,"median":-18.854299,"eighty":-13.535387,"marketCap":2885540665},{"date":"2022-04-01","current":6.332541,"twenty":-29.059361,"median":-18.812466,"eighty":-13.401373,"marketCap":3347280093},{"date":"2022-04-08","current":5.550705,"twenty":-29.024675,"median":-18.794758,"eighty":-13.265359,"marketCap":2934013648},{"date":"2022-04-14","current":5.991356,"twenty":-28.703811,"median":-18.761922,"eighty":-13.220571,"marketCap":3166934894},{"date":"2022-04-22","current":5.372942,"twenty":-28.574536,"median":-18.734105,"eighty":-13.141809,"marketCap":2840051100},{"date":"2022-04-29","current":5.095031,"twenty":-28.505894,"median":-18.668639,"eighty":-13.059426,"marketCap":2693151905},{"date":"2022-05-06","current":2.349009,"twenty":-28.469299,"median":-18.594985,"eighty":-12.976103,"marketCap":2856667584},{"date":"2022-05-13","current":2.463303,"twenty":-28.388246,"median":-18.543324,"eighty":-12.895366,"marketCap":2995662068},{"date":"2022-05-20","current":2.651615,"twenty":-28.246809,"median":-18.442293,"eighty":-12.8103,"marketCap":3224672027},{"date":"2022-05-27","current":2.906327,"twenty":-28.076629,"median":-18.398749,"eighty":-12.701527,"marketCap":3534431163},{"date":"2022-06-03","current":2.727811,"twenty":-28.021409,"median":-18.391807,"eighty":-12.534152,"marketCap":3317335016},{"date":"2022-06-10","current":2.51664,"twenty":-27.965895,"median":-18.363419,"eighty":-12.358311,"marketCap":3060526160},{"date":"2022-06-17","current":2.67012,"twenty":-27.888859,"median":-18.341211,"eighty":-12.305838,"marketCap":3247175896},{"date":"2022-06-24","current":2.703864,"twenty":-27.837744,"median":-18.22838,"eighty":-12.195459,"marketCap":3288212363},{"date":"2022-07-01","current":2.815981,"twenty":-27.778501,"median":-18.164236,"eighty":-12.079297,"marketCap":3424559333},{"date":"2022-07-08","current":3.239412,"twenty":-27.688116,"median":-18.122158,"eighty":-11.859947,"marketCap":3939500802},{"date":"2022-07-15","current":3.158862,"twenty":-27.501277,"median":-18.071876,"eighty":-11.675276,"marketCap":3841542784},{"date":"2022-07-22","current":3.15342,"twenty":-27.382511,"median":-18.023893,"eighty":-11.508907,"marketCap":3834924000},{"date":"2022-07-29","current":3.027152,"twenty":-27.14694,"median":-17.960973,"eighty":-10.547315,"marketCap":3681368189},{"date":"2022-08-05","current":3.284041,"twenty":-27.105397,"median":-17.914058,"eighty":-10.342823,"marketCap":3993774838},{"date":"2022-08-12","current":3.519584,"twenty":-26.973986,"median":-17.798161,"eighty":-10.237383,"marketCap":3793443310},{"date":"2022-08-19","current":3.033488,"twenty":-26.947966,"median":-17.767556,"eighty":-10.103184,"marketCap":3269523692},{"date":"2022-08-26","current":3.002722,"twenty":-26.854358,"median":-17.71336,"eighty":-10.041677,"marketCap":3236364223},{"date":"2022-09-02","current":2.916579,"twenty":-26.786483,"median":-17.683957,"eighty":-9.935437,"marketCap":3143517708},{"date":"2022-09-09","current":2.754136,"twenty":-26.702977,"median":-17.655692,"eighty":-9.881119,"marketCap":2968435709},{"date":"2022-09-16","current":2.463709,"twenty":-26.472342,"median":-17.613678,"eighty":-9.729347,"marketCap":2655410317},{"date":"2022-09-23","current":2.28773,"twenty":-26.464937,"median":-17.538747,"eighty":-9.545624,"marketCap":2465738152},{"date":"2022-09-30","current":2.372643,"twenty":-26.436863,"median":-17.384908,"eighty":2.244512,"marketCap":2557258287},{"date":"2022-10-07","current":2.536316,"twenty":-26.160602,"median":-17.196397,"eighty":2.28773,"marketCap":2733666665},{"date":"2022-10-14","current":2.5437,"twenty":-25.803947,"median":-17.042661,"eighty":2.338185,"marketCap":2741624938},{"date":"2022-10-21","current":2.613845,"twenty":-25.275277,"median":-16.992473,"eighty":2.372643,"marketCap":2817228528},{"date":"2022-10-28","current":2.787363,"twenty":-25.158273,"median":-16.959205,"eighty":2.425205,"marketCap":3004247936},{"date":"2022-11-04","current":2.989205,"twenty":-24.996928,"median":-16.68897,"eighty":2.463709,"marketCap":3415746834},{"date":"2022-11-11","current":3.186078,"twenty":-24.749148,"median":-16.563886,"eighty":2.506781,"marketCap":3640712234},{"date":"2022-11-18","current":3.147635,"twenty":-24.714305,"median":-16.491884,"eighty":2.522083,"marketCap":3596784079},{"date":"2022-11-25","current":3.172099,"twenty":-24.700691,"median":-16.413203,"eighty":2.536961,"marketCap":3624738359},{"date":"2022-12-02","current":3.216366,"twenty":-24.589864,"median":-16.353453,"eighty":2.57769,"marketCap":3675322295},{"date":"2022-12-09","current":2.961247,"twenty":-24.543652,"median":-16.280515,"eighty":2.61483,"marketCap":3383799085},{"date":"2022-12-16","current":3.106863,"twenty":-24.338293,"median":-16.218215,"eighty":2.637719,"marketCap":3550193612},{"date":"2022-12-23","current":2.99736,"twenty":-24.195966,"median":-16.158379,"eighty":2.659019,"marketCap":3425064928},{"date":"2022-12-30","current":2.948433,"twenty":-24.086482,"median":-16.089546,"eighty":2.672384,"marketCap":3369156367},{"date":"2023-01-06","current":3.034637,"twenty":-24.015029,"median":-15.986241,"eighty":2.695559,"marketCap":3467661927},{"date":"2023-01-13","current":3.095214,"twenty":-23.980455,"median":-15.939266,"eighty":2.71213,"marketCap":3536882049},{"date":"2023-01-20","current":3.214036,"twenty":-23.959041,"median":-15.899579,"eighty":2.720845,"marketCap":3672659983},{"date":"2023-01-27","current":3.593803,"twenty":-23.94781,"median":-15.806573,"eighty":2.736169,"marketCap":4106616907},{"date":"2023-02-03","current":3.511093,"twenty":-23.909293,"median":-15.691293,"eighty":2.752659,"marketCap":4012104816},{"date":"2023-02-10","current":3.046287,"twenty":-23.876098,"median":-15.598376,"eighty":2.785467,"marketCap":3480973489},{"date":"2023-02-17","current":2.998525,"twenty":-23.786557,"median":-15.547358,"eighty":2.817723,"marketCap":3426396084},{"date":"2023-02-24","current":5.93943,"twenty":-23.68312,"median":-15.500916,"eighty":2.889021,"marketCap":3063777617},{"date":"2023-03-03","current":5.912443,"twenty":-23.677357,"median":-15.480435,"eighty":2.916579,"marketCap":3049856696},{"date":"2023-03-10","current":5.852904,"twenty":-23.562111,"median":-15.423336,"eighty":2.923969,"marketCap":3019144479},{"date":"2023-03-17","current":6.127299,"twenty":-23.481585,"median":-15.367834,"eighty":2.948433,"marketCap":3160687740},{"date":"2023-03-24","current":5.82184,"twenty":-23.421616,"median":-15.353884,"eighty":2.972896,"marketCap":3003120713},{"date":"2023-03-31","current":6.023754,"twenty":-23.325856,"median":-15.239849,"eighty":2.984545,"marketCap":3107275189},{"date":"2023-04-06","current":6.005634,"twenty":-23.152066,"median":-15.17812,"eighty":2.992385,"marketCap":3097927992},{"date":"2023-04-14","current":6.426064,"twenty":-23.077045,"median":-15.168249,"eighty":2.999364,"marketCap":3314801506},{"date":"2023-04-21","current":6.42866,"twenty":-23.013768,"median":-15.145191,"eighty":3.017675,"marketCap":3316140820},{"date":"2023-04-28","current":6.358558,"twenty":-22.974078,"median":-15.063308,"eighty":3.029686,"marketCap":3279979349},{"date":"2023-05-05","current":6.620793,"twenty":-22.824838,"median":-14.971692,"eighty":3.041627,"marketCap":3415250037},{"date":"2023-05-12","current":-22.604019,"twenty":-22.803493,"median":-15.063308,"eighty":3.039194,"marketCap":3247835819},{"date":"2023-05-19","current":-23.208402,"twenty":-23.036153,"median":-15.145191,"eighty":3.036433,"marketCap":3334676030},{"date":"2023-05-26","current":-24.028948,"twenty":-23.253159,"median":-15.168702,"eighty":3.033948,"marketCap":3452575384},{"date":"2023-06-02","current":-25.07328,"twenty":-23.457597,"median":-15.17812,"eighty":3.030954,"marketCap":3602629106},{"date":"2023-06-09","current":-24.131516,"twenty":-23.680815,"median":-15.244874,"eighty":3.027152,"marketCap":3467312803},{"date":"2023-06-16","current":-24.22476,"twenty":-23.89661,"median":-15.356365,"eighty":3.025952,"marketCap":3480710457},{"date":"2023-06-23","current":-23.227051,"twenty":-23.876098,"median":-15.367834,"eighty":3.023011,"marketCap":3337355561},{"date":"2023-06-30","current":-23.282997,"twenty":-23.812416,"median":-15.420856,"eighty":3.018444,"marketCap":3345394153},{"date":"2023-07-07","current":-21.296902,"twenty":-23.732018,"median":-15.459754,"eighty":3.017419,"marketCap":3060024127},{"date":"2023-07-14","current":-21.791095,"twenty":-23.68888,"median":-15.494735,"eighty":3.007844,"marketCap":3131031693},{"date":"2023-07-21","current":-11.841973,"twenty":-23.67851,"median":-15.506154,"eighty":3.00328,"marketCap":1701502032},{"date":"2023-07-28","current":-12.830358,"twenty":-23.637871,"median":-15.492788,"eighty":2.999364,"marketCap":1843517162},{"date":"2023-08-04","current":-7.158181,"twenty":-23.575289,"median":-15.437381,"eighty":2.997593,"marketCap":1875200001},{"date":"2023-08-11","current":-6.856931,"twenty":-23.532767,"median":-15.374802,"eighty":2.996727,"marketCap":1796282661},{"date":"2023-08-18","current":-6.513572,"twenty":-23.490354,"median":-15.356365,"eighty":2.995585,"marketCap":1706334277},{"date":"2023-08-25","current":-6.585318,"twenty":-23.445604,"median":-15.283186,"eighty":2.993124,"marketCap":1725129462},{"date":"2023-09-01","current":-6.487948,"twenty":-23.36416,"median":-15.18466,"eighty":2.990182,"marketCap":1699621711},{"date":"2023-09-08","current":-5.924224,"twenty":-23.323632,"median":-15.169155,"eighty":2.987839,"marketCap":1551945259},{"date":"2023-09-15","current":-5.14526,"twenty":-23.305376,"median":-15.153389,"eighty":2.985291,"marketCap":1347883252},{"date":"2023-09-22","current":-4.684032,"twenty":-23.264348,"median":-15.084962,"eighty":2.984432,"marketCap":1227057064},{"date":"2023-09-29","current":-4.719905,"twenty":-23.232645,"median":-14.994118,"eighty":2.982978,"marketCap":1236454657},{"date":"2023-10-06","current":-4.596911,"twenty":-23.219591,"median":-14.905062,"eighty":2.980119,"marketCap":1204234340},{"date":"2023-10-13","current":-4.268926,"twenty":-23.204672,"median":-14.813446,"eighty":2.976391,"marketCap":1118313495},{"date":"2023-10-20","current":-4.202304,"twenty":-23.195348,"median":-14.715168,"eighty":2.972393,"marketCap":1100860824},{"date":"2023-10-27","current":-4.156181,"twenty":-23.191618,"median":-14.70401,"eighty":2.97189,"marketCap":1088778205},{"date":"2023-11-03","current":-1.833784,"twenty":-23.16178,"median":-14.654402,"eighty":2.970995,"marketCap":1101537686},{"date":"2023-11-10","current":-1.822736,"twenty":-23.122424,"median":-14.624185,"eighty":2.964975,"marketCap":1095003259},{"date":"2023-11-17","current":-2.158621,"twenty":-23.084939,"median":-14.571914,"eighty":2.953559,"marketCap":1296785187},{"date":"2023-11-24","current":-2.185492,"twenty":-23.047152,"median":-14.501953,"eighty":2.943307,"marketCap":1312927741},{"date":"2023-12-01","current":-2.125033,"twenty":-22.99923,"median":-14.394226,"eighty":2.935153,"marketCap":1276606994},{"date":"2023-12-08","current":-2.147425,"twenty":-22.975001,"median":-14.247611,"eighty":2.933522,"marketCap":1290059123},{"date":"2023-12-15","current":-2.248191,"twenty":-22.965997,"median":-14.127304,"eighty":2.928862,"marketCap":1350593701},{"date":"2023-12-22","current":-2.214602,"twenty":-22.956644,"median":-14.062197,"eighty":2.923503,"marketCap":1330415508},{"date":"2023-12-29","current":-2.304171,"twenty":-22.956644,"median":-14.011161,"eighty":2.922804,"marketCap":1384224022},{"date":"2024-01-05","current":-2.299693,"twenty":-22.923076,"median":-13.974763,"eighty":2.922761,"marketCap":1381533596},{"date":"2024-01-12","current":-2.315368,"twenty":-22.862509,"median":-13.914045,"eighty":2.920679,"marketCap":1390950086},{"date":"2024-01-19","current":-2.19221,"twenty":-22.814679,"median":-13.865638,"eighty":2.918218,"marketCap":1316963380},{"date":"2024-01-26","current":-2.172057,"twenty":-22.765546,"median":-13.84578,"eighty":2.912478,"marketCap":1304856464},{"date":"2024-02-02","current":-2.042181,"twenty":-22.73594,"median":-13.738854,"eighty":2.904997,"marketCap":1226834119},{"date":"2024-02-09","current":-2.066813,"twenty":-22.719508,"median":-13.659429,"eighty":2.902155,"marketCap":1241631460},{"date":"2024-02-16","current":-2.30865,"twenty":-22.699526,"median":-13.600205,"eighty":2.896139,"marketCap":1386914448},{"date":"2024-02-23","current":-2.257089,"twenty":-22.676089,"median":-13.54948,"eighty":2.888128,"marketCap":1388247245},{"date":"2024-03-01","current":-2.467662,"twenty":-22.632584,"median":-13.493559,"eighty":2.87389,"marketCap":1517762692},{"date":"2024-03-08","current":-2.472053,"twenty":-22.607531,"median":-13.392896,"eighty":2.828608,"marketCap":1520463337},{"date":"2024-03-15","current":-2.309591,"twenty":-22.604019,"median":-13.285202,"eighty":2.817723,"marketCap":1420539459},{"date":"2024-03-22","current":-2.215188,"twenty":-22.594624,"median":-13.26784,"eighty":2.814675,"marketCap":1362475584},{"date":"2024-03-28","current":-2.217383,"twenty":-22.557046,"median":-13.235471,"eighty":2.80945,"marketCap":1363825906},{"date":"2024-04-05","current":-2.079071,"twenty":-22.536419,"median":-13.212102,"eighty":2.800742,"marketCap":1278755577},{"date":"2024-04-12","current":-2.028576,"twenty":-22.501485,"median":-13.166121,"eighty":2.787363,"marketCap":1247698156},{"date":"2024-04-19","current":-1.747561,"twenty":-22.437199,"median":-13.128738,"eighty":2.777883,"marketCap":1074856853},{"date":"2024-04-26","current":-1.685182,"twenty":-22.410221,"median":-13.087868,"eighty":2.77244,"marketCap":1036489544},{"date":"2024-05-03","current":-2.311758,"twenty":-22.314051,"median":-13.07974,"eighty":2.771365,"marketCap":1247047708},{"date":"2024-05-10","current":-2.411257,"twenty":-22.30023,"median":-13.055872,"eighty":2.754136,"marketCap":1300720980},{"date":"2024-05-17","current":-2.504579,"twenty":-22.275407,"median":-12.996121,"eighty":2.746753,"marketCap":1351062692},{"date":"2024-05-24","current":-2.68618,"twenty":-22.229341,"median":-12.968062,"eighty":2.744291,"marketCap":1449024942},{"date":"2024-05-31","current":-2.620602,"twenty":-22.192575,"median":-12.912835,"eighty":2.740353,"marketCap":1413649685},{"date":"2024-06-07","current":-3.021637,"twenty":-22.167934,"median":-12.892121,"eighty":2.738384,"marketCap":1629982986},{"date":"2024-06-14","current":-2.613035,"twenty":-22.16154,"median":-12.838515,"eighty":2.732231,"marketCap":1409567924},{"date":"2024-06-21","current":-2.2574,"twenty":-22.156079,"median":-12.818881,"eighty":2.7281,"marketCap":1217725186},{"date":"2024-06-28","current":-2.237222,"twenty":-22.152306,"median":-12.775976,"eighty":2.727907,"marketCap":1206840491},{"date":"2024-07-05","current":-2.209478,"twenty":-22.09392,"median":-12.740239,"eighty":2.724408,"marketCap":1191874036},{"date":"2024-07-12","current":-2.310367,"twenty":-22.04462,"median":-12.643458,"eighty":2.721624,"marketCap":1246297508},{"date":"2024-07-15","current":-2.363334,"twenty":-22.040742,"median":-12.597291,"eighty":2.721452,"marketCap":1274869831},{"date":"2024-08-02","current":-2.752366,"twenty":-22.036864,"median":-12.568499,"eighty":2.72128,"marketCap":1329503025},{"date":"2024-08-09","current":-2.438376,"twenty":-22.021289,"median":-12.443095,"eighty":2.719103,"marketCap":1177833102},{"date":"2024-08-16","current":-2.449691,"twenty":-21.94023,"median":-12.357937,"eighty":2.719103,"marketCap":1183298684},{"date":"2024-08-23","current":-2.353514,"twenty":-21.905091,"median":-12.320329,"eighty":2.713661,"marketCap":1136841230},{"date":"2024-08-30","current":-2.347856,"twenty":-21.900698,"median":-12.278187,"eighty":2.709834,"marketCap":1134108439},{"date":"2024-09-06","current":-2.163988,"twenty":-21.896445,"median":-12.196913,"eighty":2.705896,"marketCap":1045292718},{"date":"2024-09-13","current":-2.223391,"twenty":-21.889093,"median":-12.123273,"eighty":2.704073,"marketCap":1073987028},{"date":"2024-09-20","current":-2.246021,"twenty":-21.855137,"median":-12.011668,"eighty":2.698795,"marketCap":1084918193},{"date":"2024-09-27","current":-2.064982,"twenty":-21.833743,"median":-11.855748,"eighty":2.69359,"marketCap":997468868},{"date":"2024-10-04","current":-2.073468,"twenty":-21.823392,"median":-11.774328,"eighty":2.689421,"marketCap":1001568055},{"date":"2024-10-11","current":-2.076297,"twenty":-21.814607,"median":-11.632392,"eighty":2.682833,"marketCap":1002934451},{"date":"2024-10-18","current":-2.183789,"twenty":-21.814607,"median":-10.863639,"eighty":2.682833,"marketCap":1054857488},{"date":"2024-10-25","current":-2.079126,"twenty":-21.814607,"median":-10.368385,"eighty":2.682833,"marketCap":1004300846},{"date":"2024-10-31","current":-2.149844,"twenty":-21.814607,"median":-10.256553,"eighty":2.682833,"marketCap":1038460739},{"date":"2024-11-08","current":-2.52281,"twenty":-21.818121,"median":-10.088806,"eighty":2.685729,"marketCap":1345525572},{"date":"2024-11-15","current":-2.231021,"twenty":-21.818121,"median":-10.004932,"eighty":2.685729,"marketCap":1189901836},{"date":"2024-11-22","current":-1.794629,"twenty":-21.818121,"median":-9.881119,"eighty":2.685729,"marketCap":957154834},{"date":"2024-11-29","current":-2.055432,"twenty":-21.818121,"median":-9.841179,"eighty":2.685729,"marketCap":1096252155},{"date":"2024-12-06","current":-2.058014,"twenty":-21.818121,"median":-9.693402,"eighty":2.685729,"marketCap":1097629356},{"date":"2024-12-13","current":-1.918575,"twenty":-21.818121,"median":-6.887679,"eighty":2.685729,"marketCap":1023260491},{"date":"2024-12-20","current":-1.903082,"twenty":-21.818121,"median":-6.726249,"eighty":2.685729,"marketCap":1014997284},{"date":"2024-12-27","current":-1.910828,"twenty":-21.818121,"median":-6.610942,"eighty":2.685729,"marketCap":1019128888},{"date":"2025-01-03","current":-1.87726,"twenty":-21.818121,"median":-6.549445,"eighty":2.685729,"marketCap":1001225272},{"date":"2025-01-10","current":-3.222586,"twenty":-21.821635,"median":-6.293207,"eighty":2.688625,"marketCap":1718747097},{"date":"2025-01-17","current":-2.595112,"twenty":-21.821635,"median":-5.498869,"eighty":2.688625,"marketCap":1384087206},{"date":"2025-01-24","current":-2.892065,"twenty":-21.821635,"median":-5.04789,"eighty":2.688625,"marketCap":1542465344},{"date":"2025-01-31","current":-2.662249,"twenty":-21.821635,"median":-4.791652,"eighty":2.688625,"marketCap":1419894437},{"date":"2025-02-07","current":-2.641591,"twenty":-21.821635,"median":-4.704531,"eighty":2.688625,"marketCap":1408876827},{"date":"2025-02-14","current":-2.473748,"twenty":-21.821635,"median":-4.550788,"eighty":2.688625,"marketCap":1319358749},{"date":"2025-02-21","current":-2.530557,"twenty":-21.821635,"median":-4.381671,"eighty":2.688625,"marketCap":1349657176},{"date":"2025-02-28","current":-2.12802,"twenty":-21.791095,"median":-4.268926,"eighty":2.688625,"marketCap":1110741107},{"date":"2025-03-07","current":-2.120366,"twenty":-21.64111,"median":-3.5997,"eighty":2.689421,"marketCap":1106746318},{"date":"2025-03-14","current":-1.839227,"twenty":-21.53137,"median":-2.879923,"eighty":2.689421,"marketCap":960003002},{"date":"2025-03-21","current":-1.80507,"twenty":-21.481532,"median":-2.748622,"eighty":2.689421,"marketCap":942174374},{"date":"2025-03-28","current":-1.752521,"twenty":-21.379869,"median":-2.708835,"eighty":2.689421,"marketCap":914745717},{"date":"2025-04-04","current":-1.565971,"twenty":-21.296902,"median":-2.67483,"eighty":2.689421,"marketCap":817373984},{"date":"2025-04-11","current":-1.387303,"twenty":-21.293338,"median":-2.643302,"eighty":2.688625,"marketCap":724116550},{"date":"2025-04-17","current":-1.428029,"twenty":-21.293338,"median":-2.626098,"eighty":2.688625,"marketCap":745373759},{"date":"2025-04-25","current":-1.652677,"twenty":-21.294051,"median":-2.607938,"eighty":2.689421,"marketCap":862631268},{"date":"2025-05-02","current":-1.608221,"twenty":-21.294051,"median":-2.57738,"eighty":2.689421,"marketCap":839427283},{"date":"2025-05-09","current":-1.294675,"twenty":-21.294051,"median":-2.545082,"eighty":2.689421,"marketCap":747867596},{"date":"2025-05-16","current":-1.088867,"twenty":-21.294051,"median":-2.526952,"eighty":2.689421,"marketCap":628982913},{"date":"2025-05-23","current":-1.103226,"twenty":-21.294051,"median":-2.504011,"eighty":2.689421,"marketCap":637277193},{"date":"2025-05-30","current":-1.242026,"twenty":-21.294051,"median":-2.493065,"eighty":2.689421,"marketCap":717455235},{"date":"2025-06-06","current":-1.232454,"twenty":-21.294051,"median":-2.47986,"eighty":2.689421,"marketCap":711925715}],"updateTime":1749321317364}}}